In the News

FDA Approves US WorldMeds' MYOBLOC® (rimabotulinumtoxinB) Injection for Chronic Sialorrhea

August 2019

https://www.prnewswire.com/news-releases/fda-approves-us-worldmeds-myobloc-rimabotulinumtoxinb-injection-for-chronic-sialorrhea-300906932.html

Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

August 2019

https://www.novartis.com/news/media-releases/novartis-ofatumumab-demonstrates-superiority-versus-aubagio-two-head-head-phase-iii-multiple-sclerosis-studies

APDA Research Symposium

April 2019

Link to Symposium website  

EvergreenHealth Neurologist and Parkinson's expert Dr. Pinky Agarwal participated in the researcher panel: